204 related articles for article (PubMed ID: 20024165)
21. Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.
Wang HW; Putt ME; Emanuele MJ; Shin DB; Glatstein E; Yodh AG; Busch TM
Cancer Res; 2004 Oct; 64(20):7553-61. PubMed ID: 15492282
[TBL] [Abstract][Full Text] [Related]
22. Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model.
Cheung R; Solonenko M; Busch TM; Del Piero F; Putt ME; Hahn SM; Yodh AG
J Biomed Opt; 2003 Apr; 8(2):248-52. PubMed ID: 12683850
[TBL] [Abstract][Full Text] [Related]
23. Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice.
Coutier S; Bezdetnaya LN; Foster TH; Parache RM; Guillemin F
Radiat Res; 2002 Sep; 158(3):339-45. PubMed ID: 12175311
[TBL] [Abstract][Full Text] [Related]
24. Induction of Hsp60 by Photofrin-mediated photodynamic therapy.
Hanlon JG; Adams K; Rainbow AJ; Gupta RS; Singh G
J Photochem Photobiol B; 2001 Nov; 64(1):55-61. PubMed ID: 11705730
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent.
Henderson BW; Sitnik-Busch TM; Vaughan LA
Photochem Photobiol; 1999 Jul; 70(1):64-71. PubMed ID: 10420844
[TBL] [Abstract][Full Text] [Related]
26. Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate.
Busch TM; Wang HW; Wileyto EP; Yu G; Bunte RM
Radiat Res; 2010 Sep; 174(3):331-40. PubMed ID: 20726728
[TBL] [Abstract][Full Text] [Related]
27. Effect of photosensitizer dose on fluence rate responses to photodynamic therapy.
Wang HW; Rickter E; Yuan M; Wileyto EP; Glatstein E; Yodh A; Busch TM
Photochem Photobiol; 2007; 83(5):1040-8. PubMed ID: 17880498
[TBL] [Abstract][Full Text] [Related]
28. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
29. Short- and long-term normal tissue damage with photodynamic therapy in pig trachea: a fluence-response pilot study comparing Photofrin and mTHPC.
Murrer LH; Hebeda KM; Marijnissen JP; Star WM
Br J Cancer; 1999 May; 80(5-6):744-55. PubMed ID: 10360652
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy using intra-articular Photofrin for murine MRSA arthritis: biphasic light dose response for neutrophil-mediated antibacterial effect.
Tanaka M; Kinoshita M; Yoshihara Y; Shinomiya N; Seki S; Nemoto K; Hamblin MR; Morimoto Y
Lasers Surg Med; 2011 Mar; 43(3):221-9. PubMed ID: 21412806
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.
Schouwink H; Ruevekamp M; Oppelaar H; van Veen R; Baas P; Stewart FA
Photochem Photobiol; 2001 Apr; 73(4):410-7. PubMed ID: 11332037
[TBL] [Abstract][Full Text] [Related]
32. In vivo relaxation time measurements on a murine tumor model--prolongation of T1 after photodynamic therapy.
Liu YH; Hawk RM; Ramaprasad S
Magn Reson Imaging; 1995; 13(2):251-8. PubMed ID: 7739367
[TBL] [Abstract][Full Text] [Related]
33. Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.
Wang KK; Finlay JC; Busch TM; Hahn SM; Zhu TC
J Biophotonics; 2010 Jun; 3(5-6):304-18. PubMed ID: 20222102
[TBL] [Abstract][Full Text] [Related]
34. Effects of photodynamic therapy on adhesion molecules and metastasis.
Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T
J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074
[TBL] [Abstract][Full Text] [Related]
35. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive monitoring of murine tumor blood flow during and after photodynamic therapy provides early assessment of therapeutic efficacy.
Yu G; Durduran T; Zhou C; Wang HW; Putt ME; Saunders HM; Sehgal CM; Glatstein E; Yodh AG; Busch TM
Clin Cancer Res; 2005 May; 11(9):3543-52. PubMed ID: 15867258
[TBL] [Abstract][Full Text] [Related]
37. Optimisation of illumination for photodynamic therapy with mTHPC on normal colon and a transplantable tumour in rats.
Tsutsui H; MacRobert AJ; Curnow A; Rogowska A; Buonaccorsi G; Kato H; Bown SG
Lasers Med Sci; 2002; 17(2):101-9. PubMed ID: 12111593
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial alterations in photodynamic therapy-resistant cells.
Sharkey SM; Wilson BC; Moorehead R; Singh G
Cancer Res; 1993 Oct; 53(20):4994-9. PubMed ID: 8402690
[TBL] [Abstract][Full Text] [Related]
39. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer.
Morrison SA; Hill SL; Rogers GS; Graham RA
J Surg Res; 2014 Dec; 192(2):235-41. PubMed ID: 25043529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]